Boston Scientific Taxus plant clears inspection
This article was originally published in The Gray Sheet
Executive Summary
Paclitaxel-eluting stent manufacturing facility in Galway, Ireland generates zero FDA observations upon completion of Sept. 1-7 inspection. The review follows a July recall of nearly 100,000 units and a successfully inspection of the firm's Maple Grove, Minn. facility (1"The Gray Sheet" Sept. 6, 2004, p. 10)...